CCCC Trial readout: Wednesday, September 30, 2026
CompanyC4 Therapeutics, Inc. (CCCC)
EventTrial readout
DateWednesday, September 30, 2026
MarketUS listing
SourceCT.gov registry · confidence 70% · primary source ↗
Est. Completion: 2026-09-30. Status: ACTIVE_NOT_RECRUITING. Title: Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.